FINAMIN-D
MRP: 1,500
Packaging: 10x10
Pack Type: tablet
Composition:
Tamsulosin 0.4mg(MR) + Dutasteride 0.5mg
Indication:
Benign Prostatic Hyperplasia (BPH) Treatment.
Description:
This combination provides symptomatic relief and long-term control of benign prostatic hyperplasia (BPH) by combining two powerful mechanisms:
Tamsulosin relaxes smooth muscle in the prostate and bladder neck, providing immediate urinary symptom relief.
Dutasteride shrinks the prostate over time by inhibiting DHT (dihydrotestosterone) production.
This dual-action approach improves urinary flow, reduces prostate size, and delays disease progression.
Tags:
- Rapid improvement in urinary symptoms
- Long-term prostate volume reduction
- Reduces risk of acute urinary retention
- Lowers the need for surgical intervention
- Superior patient compliance with once-daily dose
Usage Information
Dosage
Adults (Male): 1 capsule once daily, preferably after the same meal each day Swallow the capsule whole; do not chew or crush Consistency in daily intake time enhances effectiveness
Side Effects
Decreased libido Erectile dysfunction Ejaculation disorders (e.g., retrograde ejaculation) Dizziness or orthostatic hypotension Breast tenderness or enlargement Rare: Allergic reactions or testicular pain
Contraindications
Not for use in women or children Pregnant women should not handle capsules (Dutasteride is absorbed through the skin) Use caution in patients with hepatic impairment Possible Intraoperative Floppy Iris Syndrome during cataract surgery Long-term use requires PSA monitoring (Prostate-Specific Antigen)
Availability
Tamsulosin Dutasteride capsule BPH dual therapy Urinary retention treatment Prostate shrinkage medicine Best medicine for enlarged prostate Combination therapy for BPH